Edition:
United Kingdom

Aridis Pharmaceuticals Inc (ARDS.OQ)

ARDS.OQ on NASDAQ Stock Exchange Capital Market

9.23USD
18 Jan 2019
Change (% chg)

$0.42 (+4.77%)
Prev Close
$8.81
Open
$8.85
Day's High
$9.23
Day's Low
$8.85
Volume
699
Avg. Vol
1,657
52-wk High
$13.85
52-wk Low
$7.59

Chart for

About

Aridis Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAbs), to treat infections. mAbs represents treatment approach that enables the human immune system to fight infections and are designed to overcome the... (more)

Overall

No Ratios Available.

Financials

  ARDS.OQ Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -- -- --
ROI: -- 8.99 14.48
ROE: -- 10.13 15.99

Earnings vs. Estimates